Drugs Made In America Acquisition II Corp. (DMII)

DMII Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Net Income	-0.46
Change in Other Net Operating Assets	-0.13
Operating Cash Flow	-0.58
Total Debt Issued	0.9
Total Debt Repaid	-0.15
Net Debt Issued (Repaid)	0.75
Issuance of Common Stock	0.11
Other Financing Activities	-0.22
Financing Cash Flow	0.63
Net Cash Flow	0.05
Change in Working Capital	-0.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q